Advisor Group’s Psychemedics Corporation PMD Stock Holding History

Advisor Group’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-300	Closed	-$4K	–	5385
2019 Q1	$4K	Hold	300	–	–	﹤0.01%	4794
2018 Q4	$5K	Hold	300	–	–	﹤0.01%	4544
2018 Q3	$6K	Hold	300	–	–	﹤0.01%	4536
2018 Q2	$6K	Hold	300	–	–	﹤0.01%	4324
2018 Q1	$6K	Hold	300	–	–	﹤0.01%	4352
2017 Q4	$6K	Sell	300 -100	-25%	-$1.85K	﹤0.01%	4360
2017 Q3	$7K	Buy	400 +100	+33%	+$2.2K	﹤0.01%	4156
2017 Q2	$7K	Hold	300	–	–	﹤0.01%	4116
2017 Q1	$6K	Buy	+300	New	+$6.59K	﹤0.01%	4055

Other funds holding PMD

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Advisor Group's PMD Position: Q2 2019 in Review

Advisor Group sold out of Psychemedics Corporation (PMD) in Q2 2019, closing a stake of 300 shares — an estimated $4K sold.

Advisor Group first reported a position in PMD in Q1 2017 and held it in 9 quarters. The position peaked at $7K in Q3 2017. 46 funds tracked by Wall St. Rank hold PMD as of Q2 2019.

Advisor Group reported no remaining Psychemedics Corporation position as of Q2 2019 after selling out during the quarter.
Advisor Group sold 300 Psychemedics Corporation shares in Q2 2019, an estimated $4K.
Advisor Group first reported a position in Psychemedics Corporation in Q1 2017 and held it in 9 quarters.
Advisor Group's Psychemedics Corporation position peaked at $7K in Q3 2017.
46 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.